Overexpression of TIMP-1 mediated by recombinant adenovirus in hepatocellular carcinoma cells inhibits proliferation and invasion in vitro

Hepatobiliary and Pancreatic Diseases International

Volumn 5, Issue 3, 2006, Pages 409-415

  Xia, Dong ^a,b   Yan, Lu Nan ^a   Xie, Jian Guo ^a   Tong, Yu ^c   Yan, Mao Lin ^a   Wang, Xin Ping ^a   Zhang, Ming Man ^a   Zhao, Lan Ying ^c  

^a SICHUAN UNIVERSITY   (China)

^b SOUTHWEST MEDICAL UNIVERSITY   (China)

^c Chengdu Di'Ao Pharmaceutical Company   (China)

Author keywords

Gene therapy; Hepatocellular carcinoma; Invasion; Proliferation; Tissue inhibitor of metalloproteinase

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ADENOVIRUS VECTOR; MATRIGEL; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL GROWTH; CELL INVASION; CELL PROLIFERATION; CELL STRAIN HEK293; CELL STRAIN HEPG2; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DRUG TARGETING; GENE AMPLIFICATION; GENE OVEREXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; GROWTH CURVE; GROWTH INHIBITION; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; LIVER CELL CARCINOMA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY; VIRUS RECOMBINANT; WESTERN BLOTTING;

ADENOVIRIDAE; BASE SEQUENCE; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; DNA PRIMERS; HUMANS; LIVER NEOPLASMS; MICROSCOPY, ELECTRON, TRANSMISSION; NEOPLASM INVASIVENESS; RECOMBINATION, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 33748058811     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ogasawara S, Yano H, Momosaki S, Nishida N, Takemoto Y, Kojiro S, et al. Expression of matrix metalloproteinases (MMPs) in cultured epatocellular carcinoma (HCC) cells and surgically resected HCC tissues. Oncol Rep 2005;13: 1043-1048.
2. Yang BH, Xia JL, Huang LW, Tang ZY, Chen MS, Li JQ, et al. Changed clinical aspects of primary liver cancer in China during the past 30 years. Hepatobiliary Pancreat Dis Int 2004;3:194-198.
3. Yoshiji H, Kuriyama S, Fukui H. Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor. Tumour Biol 2002;23:348-356.
4. Yang C, Zeisberg M, Lively JC, Nyberg P, Afdhal N, Kalluri R. Integrin alpha1beta1 and alpha2beta1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment. Cancer Res 2003;63:8312-8317.
5. Zucker S, Hymowitz M, Rollo EE, Mann R, Conner CE, Cao J, et al. Tumorigenic potential of extracellular matrix metalloproteinase inducer. Am J Pathol 2001;158:1921-1928.
6. Zucker S, Cao J, Chen WT. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene 2000;19:6642-6650.
7. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002;2:163-176.
8. Lakka SS, Rajan M, Gondi C, Yanamandra N, Chandrasekar N, Jasti SL, et al. Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibit tumor growth and invasion. Oncogene 2002;21:8011-8019.
9. Kim JR, Kim CH. Association of a high activity of matrix metalloproteinase-9 to low levels of tissue inhibitors of metalloproteinase-1 and -3 in human hepatitis B-viral hepatoma cells. Int J Biochem Cell Biol 2004;36:2293-2306.
10. Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinase: evolution, structure and function. Biochim Biophys Acta 2000;1447:267-283.
11. Fassina G, Ferrari N, Brigati C, Optreia M, Naferte H, Euilia L, et al. Tissue inhibitors of metalloproteinase: regulation and biological activities. Clin Exp Metastasis 2000;18:111-120.
12. Jiang Y, Goldberg ID, Shi IE. Complex roles of tissue inhibitors of metalloproteinase in cancer. Oncogene 2002; 21:2245-2252.
13. Matsumoto E, Nakatsukasa H, Nouso K, Kobayashi Y, Nakamura S, Suzuki M, et al. Increased levels of tissue inhibitor of metalloproteinase-1 in human hepatocellular carcinoma. Liver Int 2004;24:379-383.
14. Murphy G, Knauper V, Lee MH, Amour A, Worley JR, Hutton M, et al. Role of TIMPs (tissue inhibitors of metalloproteinases) in pericellular proteolysis: the specificity is in the detail. Biochem Soc Symp 2003;70:65-80.
15. Kim JR, Kim CH. Association of a high activity of matrix metalloproteinase-9 to low levels of tissue inhibitors of metalloproteinase-1 and -3 in human hepatitis B-viral hepatoma cells. Int J Biochem Cell Biol 2004;36:2293-2306.
16. Matsumoto E, Nakatsukasa H, Nouso K, Kobayashi Y, Nakamura S, Suzuki M, et al. Increased levels of tissue inhibitor of metalloproteinase-1 in human hepatocellular carcinoma. Liver Int 2004;24:379-383.
17. Xia D, Yan LN, Tong Y, Wang XP, Zhang MM, Zhao LY. Construction of recombinant adenoviral vector carrying human tissue inhibitor of metalloproteinase-1 gene and its expression in vitro. Hepatobiliary Pancreat Dis Int 2005;4: 259-264.
18. He TC, Zhou SB, Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 1998;95:2509-2514.
19. Li H, Lu H, Griscelli F, Opolon P, Sun LQ Ragot T, et al. Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice. Gene Ther 1998;5:1105-1113.
20. Xia D, Zhang MM, Yan LN. Recent advances in liver-directed gene transfer vectors. Hepatobiliary Pancreat Dis Int 2004;3:332-336.
21. Giannelli G, Bergamini C, Fransvea E, Marinosci F, Quaranta V, Antonaci S. Human hepatocellular carcinoma (HCC) cells require both alpha3beta1 integrin and matrix metalloproteinases activity for migration and invasion. Lab Invest 2001;81:613-627.
22. Li H, Lindenmeyer F, Grenet C, Opolon P, Menashi S, Soria C, et al. AdTIMP-2 inhibits tumor growth, angiogenesis, and metastasis, and prolongs survival in mice. Hum Gene Ther 2001;12:515-526.
23. Tran PL, Vigneron JP, Pericat D, Dubois S, Cazals D, Hervy M, et al. Gene therapy for hepatocellular carcinoma using non-viral vectors composed of bis guanidinium-trencholesterol and plasmids encoding the tissue inhibitors of metalloproteinases TIMP-1 and TIMP-3. Cancer Gene Ther 2003;10:435-444.
24. Jiang YF, Wang MS, Celoker MY, Liu YE, Xiang Q, Goldberg ID, et al. Stimulation of mammary tumorigenesis by systemic tissue inhibitors of matrix metalloproteinases 4 gene delivery. Cancer Res 2001;61:2365-2370.
25. Mohammed AM, Valerie AS, David LE, Andrew HB, Andrew CN. Adenovirus mediated gene delivery of tissue inhibitors of metalloproteinases-3 induces death in retinal pibment epithelial cells. Br J Ophthalmol 2002;86:97-101.
26. Cao J, Kozarekar P, Pavlaki M, Chiarelli C, Babou WF, Zucker S. Distinct roles for the catalytic and hemopexin domains of membrane type 1-matrix metalloproteinase in substrate degradation and cell migration. J Biol Chem 2004;279:14129-14139.